FOXK2 and thyroid gland papillary carcinoma: In papillary thyroid cancer, stable knockdown of FOXK2 markedly inhibited cell proliferation, significantly increased the ratio of LC3-II/LC3-I, and reduced p62 expression, whereas overexpression of FOXK2 resulted in the opposite phenotype (57).